S&P 500 · Health Care · USD · FY end 2025-12-31
Moderna (MRNA) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 8-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 1.94B | -2.82B | -7.26 | -2.06B |
| FY2024 | 3.24B | -3.56B | -9.28 | -4.05B |
| FY2023 | 6.85B | -4.71B | -12.33 | -3.83B |
| FY2022 | 19.26B | 8.36B | 20.12 | 4.58B |
| FY2021 | 18.47B | 12.20B | 28.29 | 13.34B |